CRISPR Therapeutics AG (CRSP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
立陶宛的研究人员展示了一种新的、更通用的基因编辑CRISPR系统的分子结构。 科学家们公布了著名基因编辑工具CRISPR的新版本,它可以暂时“暂停”一个给定的基因,而不是永久地关闭它。
A research group led by Jacob Corn has just discovered that the use of AZD7648 has serious side effects. The study has just ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
The payment scheme will tie gene therapy payments to improvements in health outcomes—and could potentially boost the uptake ...
It's getting harder these days to find great growth stocks trading for less than $100 a share. It almost seems like a higher ...
BNP Paribas Financial Markets reduced its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 35.5% during the ...
Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.
Fmr LLC grew its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.0% during the 3rd quarter, ...
Antimicrobial resistance (AMR) is a critical global health crisis that undermines the effectiveness of antibiotics, leading ...
Monte Rosa Therapeutics stock surged after a recent partnership with Novartis, despite limited clinical results. Can the ...
Thanks to CRISPR, our medical specialists will soon have unprecedented control over how they treat and prevent some of our ...